Adult asthma affects more than 25 million Americans, yet many sufferers unknowingly engage in daily practices that exacerbate their condition. Unlike childhood asthma, which often receives immediate ...

Please provide your email address to receive an email when new articles are posted on . Data were derived from Silberman J, et al. JAMA Netw Open. 2025;doi:10.1001 ...

Omalizumab, alone or with allergen immunotherapy for house dust mites, may reduce daily use of inhaled corticosteroids in patients with house dust mite-sensitized mild-to-moderate allergic asthma.

WASHINGTON -- Adding dupilumab (Dupixent) to a medium-dose inhaled corticosteroid (ICS) routine helped lower asthma exacerbations and improved both lung function and asthma control, according to a ...

In the VOYAGE trial, dupilumab (Dupixent) significantly reduced asthma exacerbations and improved lung function and asthma control in children (ages 6 to 11 years) with uncontrolled, ...

Add Yahoo as a preferred source to see more of our stories on Google. Weight-loss jabs like Ozempic/Wegovy have been touted as miracle drugs revolutionizing how obesity is treated. Steffen Trumpf/dpa ...

NEW YORK (Reuters Health) - People with asthma are likely to benefit from combining medications to manage their symptoms, a strategy that requires doctors and patients to work together to tweak ...

The FDA granted fast track designation to KT-621 for treating patients with moderate to severe eosinophilic asthma, according ...

A randomized trial shows that while online coaching may not keep people with asthma moving long term, it can still deliver meaningful improvements in motivation, symptom control, and quality of life.

(Salt Lake City) - An app that allows parents and doctors to monitor a child's asthma has a big impact on managing the disease. When families monitored symptoms with eAsthma Tracker and adjusted care ...

In a recent study published in the Respiratory Research journal, researchers in Hong Kong assessed the deterioration of asthma control in patients recovering from mild to moderate coronavirus disease ...